Cargando…
Novel topical allogeneic bone-marrow-derived mesenchymal stem cell treatment of hard-to-heal diabetic foot ulcers: a proof of concept study
AIM: The aim of this study was to investigate safety of treating diabetic foot ulcers with a topically administered mesenchymal stem cell product. METHOD: Individuals with diabetes, peripheral neuropathy, toe blood pressure > 39 mmHg and non-infected foot ulcers with duration of four to fifty-two...
Autores principales: | Askø Andersen, Jonas, Rasmussen, Anne, Frimodt-Møller, Marie, Engberg, Susanne, Steeneveld, Esther, Kirketerp-Møller, Klaus, O’Brien, Timothy, Rossing, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241309/ https://www.ncbi.nlm.nih.gov/pubmed/35765085 http://dx.doi.org/10.1186/s13287-022-02951-8 |
Ejemplares similares
-
The effect of needle tenotomy on hammer, mallet and claw toe deformities in patients with diabetes, a retrospective study
por: Hedegaard Andersen, Jonas, et al.
Publicado: (2019) -
Toward Machine-Learning-Based Decision Support in Diabetes Care: A Risk Stratification Study on Diabetic Foot Ulcer and Amputation
por: Schäfer, Zeinab, et al.
Publicado: (2021) -
Mitigating risk of aldosterone in diabetic kidney disease
por: Frimodt-Møller, Marie, et al.
Publicado: (2020) -
Inflammation Leads the Way on the ROADMAP to Diabetic Kidney Disease
por: Persson, Frederik, et al.
Publicado: (2019) -
Risk factors for development of nephropathy in patients with a diabetic Charcot foot
por: Jansen, Rasmus Bo, et al.
Publicado: (2021)